semaglutide and eye vision issues Can Semaglutides (Ozempic) Cause Blindness? A recent study hints at a potential GLP-1 Medications and NAION: What

Petersen KM, Bgevig S, Holst JJ, Knop FK, Christensen MB (2018) Hemodynamic effects of glucagon: a literature review

Reliable imaging tools such as magnetic resonance spectroscopy (MRS) now allow real-time measurement of brain GSH levels, facilitating early detection and therapeutic monitoring

For patients with significant obesity and metabolic risk who are not currently on pharmacotherapy, initiating a supervised GLP-1 or dual agonist program now, rather than deferring to an uncertain future approval date, is clinically sensible

Khanfar A, Al Qaroot B

A doctor plans the change safely and tracks your progress the whole way

But long-term stability requires: Muscle preservation Adequate protein intake Appetite awareness Nervous system regulation Sustainable nutrition patterns My 1:1 menopause coaching supports you to build a metabolic foundation that lasts - whether you are currently using GLP-1s, micro-dosing, or transitioning off